MoneyWorks4Me

Marksans Pharma’s arm receives marketing authorization for Gabapentin

15 May 2025 Evaluate

Marksans Pharma’s wholly owned subsidiary in UK -- Relonchem has received marketing authorization for the product Gabapentin 50 mg/ml oral solution from UK Medicines & Healthcare Products Regulatory Agency.

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..